Epsilon M&A Deal Report - NorDiag Molecular Diagnostic Business
Transaction Multiples for the Valuation of Private Companies
Biotrin International / NorDiag Molecular Diagnostic Business
No EMAT :
65007
Announced Date :
04/05/2012
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Biotrin International
Target :
NorDiag Molecular Diagnostic Business
Country :
Norway
Sector of activity :
- Medical Equipment > Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Diagnostic Medical Equipment
Business Description :
NorDiag Group molecular business unit offers products that includes: reagent kits for the extraction of nucleic acids (DNA and RNA) from biological samples of different nature (blood, plasma, serum,...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
ns | ns | ns |
|
||
| Current |
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Diagnostic Medical Equipment » = 37
| Date | Acquirer | Target | Country | Multiples | See details |
| 21/02/2013 | Care UK | UK Specialist Hospitals | United Kingdom | ** | 65000 |
| 17/10/2013 | Trinity Biotech | Lab 21 Blood Bank Screening Business | United Kingdom | ** | 64992 |
Source: Epsilon Research / EMAT
